Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung

Clinical Cancer Research

Volumn 8, Issue 3, 2002, Pages 734-744

  Piyathilake, Chandrika J ^a   Frost, Andra R ^a   Manne, Uppender ^a   Weiss, Heidi ^a   Bell, Walter C ^a   Heimburger, Douglas C ^a   Grizzle, William E ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; BRONCHUS MUCOSA; CANCER CELL CULTURE; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CELL MEMBRANE; CONTROLLED STUDY; GENE EXPRESSION; GOLGI COMPLEX; HUMAN; HUMAN TISSUE; INTERNALIZATION; LUNG CANCER; MAJOR CLINICAL STUDY; PRECANCER; PRIORITY JOURNAL; PROGNOSIS; PROTO ONCOGENE; SQUAMOUS CELL CARCINOMA; TISSUE DISTRIBUTION;

CARCINOMA, SQUAMOUS CELL; CELL MEMBRANE; CYTOPLASM; EPITHELIAL CELLS; HUMANS; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; LIGANDS; LUNG NEOPLASMS; PRECANCEROUS CONDITIONS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SURVIVAL RATE; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR CELLS, CULTURED;

EID: 0036307913     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Autocrine growth factors and cancer
2. Growth factors and cancer
3. Human squamous cell lung cancers express increased epidermal growth factor receptors
4. Epidermal growth factor receptors in non-small cell lung cancer
5. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development
6. Localized adenocarcinoma of the lung: Oncogene expression of erbB-2 and p53 in 150 patients
7. Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: An immunohistochemical study on cryosections
8. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung
9. Expression of EGF, TGF-α EGFR in squamous cell lung carcinomas
10. Squamous cell carcinoma and variants
11. Immunohistochemical evaluation of biomarkers in prostatic and colorectal neoplasia
12. Antigen as detected by the monoclonal antibody BR96 is expressed strongly in prostatic adenocarcinoma
13. Slopes of a receiver operating characteristic curve and likelihood ratios for a diagnostic test
14. An EGF-diphtheria fusion protein kills the prostate cancer cell lines DU145 and LNCaP
15. The respiratory system
16. Down-regulation of the epidermal growth factor receptor in KB cells is due to receptor internalization and subsequent degradation in lysosomes
17. Receptor-mediated endocytosis of epidermal growth factor by hepatocytes in the perfused rat liver: Ligand and receptor dynamics
18. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor α is frequent in resectable non-small cell lung cancer but does not predict tumor progression
19. Evidence for a role of EGF receptor in the progression of human lung carcinoma
20. Prognostic significance of transforming growth factor α (TGF-α) in human lung carcinoma: An immunohistochemical study
21. The epidermal growth factor receptor as a prognostic marker: Results of 370 patients and review of 3009 patients
22. Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer
23. Epidermal growth factor receptor expression as a prognostic indicator in breast cancer
24. Prognostic value of epidermal growth factor receptor expression in cervical carcinoma
25. The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer
26. Prognostic value of epidermal growth factor receptor expression in endometrioid endometrial carcinoma
27. Epidermal growth factor receptor expression in primary laryngeal cancer: An independent prognostic factor of neck node relapse
28. Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium
29. EGF and TGF-α, the ligands of hyperproduced EGFR in human esophageal carcinoma cells, act as autocrine growth factors
30. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck
31. Transforming growth factor α (TGFα), expression in dysplastic oral leukoplakia: Modulation by 13-cis retinoic acid
32. Levels of TGF-α and EGFR protein in head and neck squamous cell carcinoma and patient survival
33. Overexpression of the EGF receptor is a hallmark of squamous cell carcinomas
34. Expression of epidermal growth factor receptor (EGF-R) in human lung tumours
35. p185neu expression in human lung adenocarcinomas predicts shortened survival
36. Prognostic influence of the co-expression of epidermal growth factor receptor and c-erbB-2 protein in human lung adenocarcinoma
37. Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma
38. Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members
39. Gene therapy for lung disease: Hype or hope?